DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study
Thrombosis and Haemostasis · 01.07.2024 · 124 (07) · 669-675
DOI: 10.1055/a-2239-9265 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.07.2024. Verfasst von Adrián Segura-Díaz und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain. Hauptthemen laut MEDLINE: Dioxygenases, Thrombosis, Mutation, DNA Methyltransferase 3A. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundación DISA.
Abstract (Originalsprache)
Background
Polycythemia vera (PV) patients are classified as high or low thrombotic risk based on age and prior history of thrombosis. Despite adherence to treatment recommendations, vascular events remain frequent, leading us to question whether thrombotic risk stratification could be improved. We previously reported an association between thrombotic events and mutations in DTA genes (DNMT3A, TET2, and ASXL1). The objective of this study was to confirm this observation in a larger series of PV patients.
Methods
PV patients with a minimum follow-up of 3 years were recruited from 8 European centers. Medical history was searched for thrombotic event recorded at any time and next-generation sequencing carried out with a myeloid panel. Multivariable logistic regression evaluated the impact of variables on thrombotic risk. Kaplan–Meier thrombosis-free survival curves were compared by the log rank test. Associations in the total cohort were confirmed in a case–control study to exclude selection bias.
Results
Of the 136 patients recruited, 74 (56.1%) had a thrombotic event, with an incidence density of 2.83/100 person-years. In multivariable analysis, DTA mutation was a risk factor for thrombotic event, being predictive for shorter thrombosis-free survival in the whole cohort (p = 0.007), as well as in low-risk patients (p = 0.039) and older patients (p = 0.009), but not for patients with a prediagnostic event. A gender- and age-matched case–control study confirmed the increased risk of thrombotic event for PV patients with a DTA mutation.
Conclusion
Our results support the use of molecular testing at diagnosis to help predict which PV patients are at higher risk of developing thrombosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hematology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
- Department of Hematology and Bone Marrow Transplantation, Wrocław Medical University, Wrocław, Poland.
- Hematology Department, Hospital Clínic, Barcelona, Spain.
- Hematology Department, Hospital Morales Messeguer, Instituto Murciano de Investigación Biosanitaria, Centro de Investigación Biomédica en Red de Enfermedades Raras, Universidad Católica San Antonio de Murcia, Murcia, Sp…
- Hematology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
- Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
Förderung
- Fundación DISA
Zitieren
APA
Segura-Díaz, A., Stuckey, R., Florido, Y., Sobas, M., Álvarez-Larrán, A., Ferrer-Marín, F., Pérez-Encinas, M., Carreño-Tarragona, G., Fox, M. L., Tazón Vega, B., Cuevas, B., López Rodríguez, J. F., Sánchez-Farías, N., González-Martín, J. M., Gómez-Casares, M. T., Bilbao-Sieyro, C., & Spanish MPN Group (GEMFIN) (2024). DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study. Thrombosis and Haemostasis, 124(07), 669-675. https://doi.org/10.1055/a-2239-9265
Vancouver
Segura-Díaz A, Stuckey R, Florido Y, Sobas M, Álvarez-Larrán A, Ferrer-Marín F, et al. DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study. Thrombosis and Haemostasis. 2024;124(07):669-675. doi:10.1055/a-2239-9265
BibTeX
@article{SeguraDaz2024,
author = {Segura-Díaz, Adrián and Stuckey, Ruth and Florido, Yanira and Sobas, Marta and Álvarez-Larrán, Alberto and Ferrer-Marín, Francisca and Pérez-Encinas, Manuel and Carreño-Tarragona, Gonzalo and Fox, María L and Tazón Vega, Barbara and Cuevas, Beatriz and López Rodríguez, Juan F and Sánchez-Farías, Nuria and González-Martín, Jesús M and Gómez-Casares, María T and Bilbao-Sieyro, Cristina and Spanish MPN Group (GEMFIN), Spanish MPN Group (GEMFIN)},
title = {DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study},
journal = {Thrombosis and Haemostasis},
year = {2024},
volume = {124},
number = {07},
pages = {669--675},
doi = {10.1055/a-2239-9265}
}
EUVIMED